Bristol Myers Squibb (BMY) Profit After Tax (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Profit After Tax for 18 consecutive years, with $3.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Profit After Tax rose 158.64% year-over-year to $3.4 billion in Q2 2026; TTM through Jun 2026 was $9.6 billion, a 88.76% increase from a year earlier, with the FY2025 full-year figure at $7.1 billion, up 178.84% from the prior year.
• Profit After Tax was $3.4 billion for Q2 2026 at Bristol Myers Squibb, up from $2.8 billion in the prior quarter.
• Over five years, Profit After Tax peaked at $3.4 billion in Q2 2026 and troughed at -$11.9 billion in Q1 2024.
• A 5-year average of $1.0 billion and a median of $1.7 billion in 2022 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax plunged 625.41% in 2024 and jumped 1406.94% in 2025, its largest moves.
• Over 5 years, Profit After Tax stood at $1.6 billion in 2022, then increased by 9.24% to $1.8 billion in 2023, then slumped by 95.91% to $72.0 million in 2024, then jumped by 1406.94% to $1.1 billion in 2025, then soared by 213.0% to $3.4 billion in 2026.
• The last three Profit After Tax figures came in at $3.4 billion (Q2 2026), $2.8 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.